Prostate cancer(PCa)
Conditions
Interventions
Gold Standard:The pathological diagnosis of the prostate specimen indicates prostate cancer (PCa) or benign prostatic hyperplasia (BPH).
Index test:The prostate disease classification and subtyping diagnostic model developed through the integration of multimodal data (e.g., MRI, PSA, medical history, etc.).
Sponsors
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with prostate disease: (1) Patients aged 18 years or older; (2) Those with clear symptoms of PCa (prostate cancer) or BPH (benign prostatic hyperplasia), meeting the diagnostic criteria for prostate diseases; (3) Subjects who fully understand the patient information, declare compliance with the study procedures, and sign the informed consent form. 2.Healthy control population: (1) Patients with prostate puncture negative results and normal PSA levels for prostate hyperplasia, with biopsy or surgical pathology confirming benign conditions; (2) Individuals considered healthy during routine physical examinations conducted in the same period; (3) Observational subjects who fully understand the patient information, declare compliance with the study procedures, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients aged <18 years; 2.Patients with contraindications for contrast-enhanced MRI; 3.Patients deemed ineligible for study participation at the investigator's discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| f/tPSA;Diagnosis;PSA; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver Function Test;Renal Function Test; | — |
Countries
China
Contacts
Public ContactBin Xu
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Outcome results
None listed